MyParkinsonsTeam

Gocovri (amantadine extended-release) is a medication approved by the FDA to treat dyskinesia in people with Parkinson’s disease who are also receiving levodopa-based therapy. It is believed to work by increasing the amount of dopamine available in the brain.

Common side effects include
- Hallucinations
- Dizziness
- Dry Show Full Answer

Gocovri (amantadine extended-release) is a medication approved by the FDA to treat dyskinesia in people with Parkinson’s disease who are also receiving levodopa-based therapy. It is believed to work by increasing the amount of dopamine available in the brain.

Common side effects include:
- Hallucinations
- Dizziness
- Dry mouth
- Swelling of legs and feet
- Constipation
- Drop in blood pressure when standing
- Falls

For more details, you can visit the Gocovri page on MyParkinsonsTeam: [Gocovri — Adamas Pharmaceuticals](https://www.gocovri.com).

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Gocovri (Amantadine) for Parkinson's Disease | MyParkinsonsTeam

4 Parkinson’s Advances: How Research Is Improving Treatment | MyParkinsonsTeam